Navigation Links
Pharmalink AB Gains Exclusive Licence to Archimedes Pharma's TARGIT® Technology for Nefecon® (PL-56) Program
Date:12/13/2011

idneys through suppression of the gut immune system. It is delivered using the proprietary TARGIT drug delivery technology which enables the localized delivery of drugs to the lower small intestine or colonic regions of the gut. The concept underlying Nefecon is a patented invention by Professors Bengt Fellström and Roger Hällgren at Uppsala University (Sweden).

About Pharmalink

Pharmalink is a Swedish specialty pharma company developing high value products for niche indications. Pharmalink draws on its extensive experience of pharmaceutical product development and the excellence of medical science in Sweden to identify and progress products that address significant unmet medical needs. Pharmalink has introduced more than 15 pharmaceutical products to the market. Using a repurposing and reformulation strategy, Pharmalink minimizes the risk of product development. The Company's strategy is to apply its expertise to drive drug development and commercialise with partners. Pharmalink currently has two clinical phase projects under development, Nefecon® and BusulipoTM, and is actively in-licensing promising new projects to add to its pipeline. Visit http://www.pharmalink.se for further information.

About Archimedes Pharma

Archimedes Pharma is an international specialty pharmaceutical company providing novel and advanced treatments to address unmet needs for people living with serious or life-threatening chronic and debilitating illnesses. Archimedes Pharma markets a diverse portfolio of specialty products and has operations in the U.S. and throughout Europe. For more information, please visit: http://www.ArchimedesPharma.com.

TARGIT is a registered trademark of Archimedes Development Limited, a subsidiary of Archimedes Pharma Ltd.

For further information, please contact:

Pharmalink AB:
Johan Häggblad, M
'/>"/>

SOURCE Pharmalink AB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development
2. Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R)
3. Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome
4. PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKessons Patent Application
5. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
6. Massachusetts Company May Have Silver Bullet In Vitamin D Fight Against Disease
7. UCF professor develops vaccine to protect against black plague bioterror attack
8. New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS
9. Integrated BioTherapeutics Awarded NIAID Contract For Up to $65 Million for Development of a Vaccine against Ebola and Marburg Viruses
10. The Plasmodium vivax genome provides new routes and challenges in the global fight against malaria
11. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 This is a ... and China Isopropanol (IPA) industry. The report provides ... applications and industry chain structure. Global market analysis ... a focus on history, developments, trends and competitive ... international and Chinese situation is also offered. , ...
(Date:9/23/2014)... New York , September 23, 2014 /PRNewswire/ ... a leading provider of  Closed System Transfer     ... new exclusive partnership with Taiwanese distributor MedFront Medical Technology Corporation. ... bodies in Taiwan , ... approval as the company continues to expand globally, ...
(Date:9/23/2014)... Greenville, SC (PRWEB) September 23, 2014 ... ) my third book on healthcare offers a three ... a 21st century healthcare delivery system that would go ... each state’s responsibility regarding the delivery of healthcare.” , ... patient safety has failed to provide discernable progress throughout ...
(Date:9/23/2014)... England , September 23, 2014 ... launched with funding from Imperial Innovations, Cambridge Innovation Capital ... Inivata, a clinical cancer genomics company focused on ... analysis to improve cancer testing and treatment, today ... round led by Imperial Innovations and including Cambridge ...
Breaking Biology Technology:(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 4
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer and ... has received FDA clearance for the,marketing of the ATS 3f(R) ... an improved valve holder accessory device. , ... While the ATS 3f Aortic ...
... Cytopia,s (ASX: CYT) JAK2 inhibitor CYT387 will be presented at the 50th ... be presented by Dr Thomas Bumm of Oregon Health and Sciences ... model of myeloproliferative disorders. , , Full ... CYT387, a Potent Novel JAK2 Inhibitor on JAK2-V617F Induc e ...
... http://www.yourwaytransport.com ), a premium global courier that provides,customized ... biotechnology and medical/healthcare industries, today,announced that it is ... The,expansion includes a new, larger facility, enhanced web ... The company has relocated ...
Cached Biology Technology:ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis 2ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis 3Yourway Transport Expands 2
(Date:9/23/2014)... gotten a lot greener thanks to a novel technique ... uses solar energy to accelerate tailings pond reclamation efforts ... a light source to treat oil sands process affected ... El-Din and James Bolton have found that using the ... just as efficiently but at a much lower cost. ...
(Date:9/23/2014)... A multidisciplinary team at the University of Wisconsin-Madison and ... more affordable way to screen for neural toxins, helping ... National Institutes of Health (NIH) announced today that the ... support to continue the promising work as part of ... will receive approximately $7 million over the three-year project. ...
(Date:9/23/2014)... soils store four times more carbon than the ... can have a big effect on atmospheric greenhouse ... Nature Climate Change concludes that climate ... or affect soil carbon storage, despite increases in ... U.S. Forest Service Research Ecologist Dr. Christian Giardina, ...
Breaking Biology News(10 mins):Solar energy-driven process could revolutionize oil sands tailings reclamation 2UW-Madison team developing 'tissue chip' to screen neurological toxins 2UW-Madison team developing 'tissue chip' to screen neurological toxins 3Study helps assess impact of temperature on belowground soil decomposition 2
... Zoo-based Wildlife Conservation Society (WCS) warn that efforts to ... beyond must focus on better management practices on farms ... Mongolian agencies on the ground in Mongolia's Kovsgol province, ... the virus. , "We're working with our Mongolian and ...
... anyone with respiratory problems, air pollution can significantly impair ... satellites and stations on the ground to develop a ... quality forecasts. , Understanding how tropospheric or near-surface-level ozone ... region to region and continent to continent is an ...
... may have a surprisingly close-to-home answer, according to one University ... is important in obtaining clues as to where else in ... be like, said George E. Fox, a UH professor of ... research grant from NASA's Exobiology Program that seeks to understand ...
Cached Biology News:WCS says avian flu prevention should focus on farms, markets 2Sensor web simulation investigates technique to improve prediction of pollution across the globe 2Sensor web simulation investigates technique to improve prediction of pollution across the globe 3Evolution of life on Earth may hold key to finding life in outer space 2Evolution of life on Earth may hold key to finding life in outer space 3
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Monoclonal Mouse Anti-Human Cytokeratin 16 (48 kD)...
Mouse monoclonal [CRC64] to Integrin alpha 2b + beta 3 ( Abpromise for all tested applications). Antigen: Human platelets Entrez Gene ID: 23295 Swiss Protein ID: P05106...
PFM8 Antibody...
Biology Products: